COVID-19 - Updates Archives

October 18, 2023

Lower COVID-19 Mortality and Hospitalization Rates in CLL and MBL: Do Repeated Vaccination and Anti-Viral Therapy Help?

The overall hospitalization rate was only 5.2%, and the mortality rate (MR) was 1.3% in COVID-19-infected patients with chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL), a CLL precursor.

September 16, 2023

CLL Society’s COVID-19 Update for the Week of September 18, 2023

It’s been a while since our last COVID-19 Update in May when the end of the public health emergency was declared, resulting in a severe lack of funding for tracking the disease metrics

August 25, 2023

New COVID-19 Vaccine Clinical Trial Specifically for Those with CLL and Other Blood Cancers

Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.

July 10, 2023

Nurses Note: The Importance of Advocating for Your Safety in Healthcare Settings

We have for a very long time known that those with CLL / SLL are at risk for having difficulty fighting off infections

July 3, 2023

Study Understanding Pre-Exposure Prophylaxis of Novel Antibodies (SUPERNOVA)

Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.

June 1, 2023

FDA Approved Paxlovid for Treatment of COVID-19

Paxlovid is now fully approved for treating mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19.

May 31, 2023

ASH 2022: Dr. Lee Greenberger on Breakthrough COVID-19 Infections in Patients with Blood Cancers

Approx. 10% of blood cancer patients who were vaccinated against COVID-19 reported a breakthrough infection during the original Omicron surge

May 31, 2023

ASH 2022: Dr. Clare Sun on Methods to Improve the Response to COVID-19 Vaccination in Patients with CLL

Interrupting BTKi therapy around the time of COVID-19 vaccination may result in a more robust antibody response for patients with CLL

May 31, 2023

ASH 2022: Dr. Andrew Rawstron on B Cells and Antibody Responses to COVID-19 Vaccination in Patients Who Are in Watch and Wait with Untreated CLL

Watch and wait patients with early-stage untreated CLL / SLL produced detectable antibodies in response to COVID-19 vaccination

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

COVID-19 – Updates

Lower COVID-19 Mortality and Hospitalization Rates in CLL and MBL: Do Repeated Vaccination and Anti-Viral Therapy Help?

CLL Society’s COVID-19 Update for the Week of September 18, 2023

New COVID-19 Vaccine Clinical Trial Specifically for Those with CLL and Other Blood Cancers

Nurses Note: The Importance of Advocating for Your Safety in Healthcare Settings

Study Understanding Pre-Exposure Prophylaxis of Novel Antibodies (SUPERNOVA)

FDA Approved Paxlovid for Treatment of COVID-19

ASH 2022: Dr. Lee Greenberger on Breakthrough COVID-19 Infections in Patients with Blood Cancers

ASH 2022: Dr. Clare Sun on Methods to Improve the Response to COVID-19 Vaccination in Patients with CLL

ASH 2022: Dr. Andrew Rawstron on B Cells and Antibody Responses to COVID-19 Vaccination in Patients Who Are in Watch and Wait with Untreated CLL

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT